Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear Basement Membrane Extract in the Cultrex product line.


    /Biotechnology News Articles/ - GAITHERSBURG, MD, January 10, 2008 - Trevigen announces the immediate availability of PathClear Basement Membrane Extract in the Cultrex product line.

The PathClear designation means that in addition to standard sterility, endotoxin and MAP testing, the BME is tested by PCR and is clear of a battery of 31 pathogens, including LDEV. Each lot is rigorously qualified in biological performance assays. Available in reduced growth factor form, with and without phenol red, PathClear BME is expected to be of special interest for in vivo murine research work and other work requiring BME free from viruses, bacteria and mycoplasma.

Trevigen, Inc. develops, manufactures and markets an extensive line of Cultrex brand products for the promotion of cell growth, cellular differentiation and for the study of cancer cell behavior. For details, contact Trevigen, at 800-873-8443, info@trevigen.com or visit the website at www.trevigen.com.

2007 Trevigen, Inc. Trevigen and Cultrex are registered trademarks and PathClear is a trademark of Trevigen, Inc.

Further Related Resources:


Press Release Contact Information:

Belinda DeLeon
Trevigen
Business Development
8405 Helgerman Court
Gaithersburg, MD
USA 20877
Voice: 1-800-873-8443
Fax: 301-560-4973
Website: Visit Our Website